Back to News
Market Impact: 0.42

Evercore ISI keeps Amphenol stock Outperform rating at $180

APHEVR
Corporate EarningsCorporate Guidance & OutlookAnalyst InsightsCompany FundamentalsArtificial Intelligence
Evercore ISI keeps Amphenol stock Outperform rating at $180

Amphenol beat March quarter expectations with revenue of $7.62B versus $7.08B consensus and EPS of $1.06 versus $0.94, while orders hit a record $9.4B and book-to-bill improved to 1.24x. Management guided June quarter revenue to $8.1B-$8.2B versus $7.7B expected and EPS to $1.14-$1.16 versus $1.05, driven in part by AI-related datacom demand. Evercore ISI kept an Outperform rating and $180 target but removed the stock from its Tactical Outperform list.

Analysis

The key second-order signal is not just that APH is comping a strong quarter, but that AI-linked content is now large enough to dominate the company’s near-term earnings power and re-rate the entire industrial hardware supply chain. When one interconnect/franchise name prints this kind of AI-driven mix, it usually front-loads optimism for adjacent beneficiaries in optics, connectors, sockets, and thermal/power infrastructure, while also creating a timing problem: the market tends to extrapolate a multi-quarter acceleration that can outrun real deployment cadence. That makes the setup bullish for the ecosystem, but also vulnerable to any pause in hyperscaler capex digestion over the next 1-2 quarters. The more interesting read-through is margin durability. A business growing this fast should be getting more operating leverage, so any sequential margin giveback—despite strong demand—can imply acquisition dilution, product mix, or capacity investment is still outrunning pricing power. That matters because the market may be valuing APH as a pure AI growth proxy, when in reality it is still partially exposed to cyclical end markets that can mask as secular strength until the order book normalizes. On the counterview, the consensus may be underestimating how quickly expectations can become too clean: after a multi-quarter beat-and-raise pattern, the stock is increasingly hostage to guidance cadence rather than fundamentals. The risk over the next 30-90 days is not a demand collapse, but a de-rating if AI sequential growth decelerates from 'extraordinary' to merely 'good.' Conversely, if AI orders stay above-book-to-bill and management confirms capacity expansions are self-funding, this can remain a quality compounder for 12+ months.